Cantel Medical (CMN -1%) fades off a 52-week high on profit-taking today after company posted a mixed FQ2 earnings report, missing on revenue estimates. Sales hit a record however, driven by a 36% Y/Y increase from its healthcare disposables segment. Organic sales growth was 11%, about half of which was driven by distributor customers pulling forward shipments in anticipation of January 1 price increases.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs